Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features

Blood (2024) 144 (2): 187–200.

https://doi.org/10.1182/blood.2023023242

Published: 2024

Includes: Supplemental data

Journal Articles

The Position of MYC Rearrangements in the Genomic Landscape of Diffuse Large B-Cell Lymphoma

Erik Van Dijk, Jurriaan Janssen, Matias Mendeville, G. Tjitske Los-De Vries, Margaretha GM Roemer, Phylicia Stathi, Julia Richter, Yong Soo Kim, Wolfram Klapper, Ulrich Dührsen, Andreas Hüttmann, P. J Lugtenburg, Josée M. Zijlstra, Marie Jose Kersten, Daphne de Jong, Martine E.D. Chamuleau, Bauke Ylstra

Blood (2022) 140 (Supplement 1): 9261–9263.

https://doi.org/10.1182/blood-2022-160052

Published: 2022

Journal Articles

An EZH2 Gene Expression Signature Is Predictive of Differential Efficacy of Chemotherapy Irrespective of EZH2 Mutation Status in Patients with Follicular Lymphoma Treated within the Gallium Trial

Verena Passerini, Vindi Jurinovic, Christopher R Bolen, Andrea Knapp, Alessia Bottos, Julia Richter, Jude Fitzgibbon, Wolfram Klapper, Andrew Davies, Robert Marcus, Michael von Bergwelt, Tina Nielsen, Martin H. Dreyling, Wolfgang Hiddemann, Michael Unterhalt, Eva Hoster, Oliver Weigert

Blood (2021) 138 (Supplement 1): 39.

https://doi.org/10.1182/blood-2021-147751

Published: 2021

Journal Articles

Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B Cell Precursor Acute Lymphoblastic Leukemia

Lennart Lenk, Dorothee Winterberg, Fotini Vogiatzi, Anna Laqua, Lea Spory, Ahmad Mayar, Christian Vokuhl, Julia Richter, Michela Carlet, Irmela Jeremias, Thomas Valerius, Martin Schrappe, Gunnar Cario, Hassan Jumaa, Elias Hobeika, Monika Brüggemann, Ameera Alsadeq, Denis Martin Schewe

Blood (2021) 138 (Supplement 1): 2388.

https://doi.org/10.1182/blood-2021-148429

Published: 2021

Journal Articles

Combining PET Radiomic Features with MYC Gene Rearrangement Results in High Prediction of Outcome in Diffuse Large B-Cell Lymphoma

Jakoba J Eertink, Gerben J.C Zwezerijnen, Sanne E Wiegers, Martine E.D Chamuleau, Pieternella Lugtenburg, Daphne De Jong, Bauke Ylstra, Matias Mendeville, Ulrich Dührsen, Andreas Hüttmann, Christine Schmitz, Julia Richter, Wolfram Klapper, Otto S Hoekstra, Henrica C.W de Vet, Ronald Boellaard, Josée M Zijlstra

Blood (2021) 138 (Supplement 1): 451.

https://doi.org/10.1182/blood-2021-145855

Published: 2021

Journal Articles

Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1

Blood (2020) 136 (25): 2851–2863.

https://doi.org/10.1182/blood.2020008553

Published: 2020

Includes: Supplemental data

Journal Articles

Evaluation of the m7-FLIPI in Patients with Follicular Lymphoma Treated within the Gallium Trial: EZH2 mutation Status May be a Predictive Marker for Differential Efficacy of Chemotherapy

Vindi Jurinovic, PhD, Verena Passerini, PhD, Mikkel Z Oestergaard, PhD, Andrea Knapp, PhD, Kirsten Mundt, PhD, Shamzah Araf, MRCP, MBBS, PhD, Julia Richter, PhD, Jude Fitzgibbon, PhD, Wolfram Klapper, Robert E. Marcus, FRCP, Andrew Davies, MD PhD, Michael Herold, MD, Wolfgang Hiddemann, PhD, Michael Unterhalt, PhD, Eva Hoster, PhD, Oliver Weigert, MD

Blood (2019) 134 (Supplement_1): 122.

https://doi.org/10.1182/blood-2019-130208

Published: 2019

Journal Articles

A New Stromal Signature Applicable to Formalin-Fixed Paraffin-Embedded Tissues Identifies Patients at Risk in Prospective Clinical Trials of the German High-Grade Non-Hodgkin Lymphoma Study Group

Blood (2018) 132 (Supplement 1): 343.

https://doi.org/10.1182/blood-2018-99-112450

Published: 2018

Journal Articles

Molecular Characteristics of Diffuse Large B-Cell Lymphoma and Correlation with Baseline Metabolic Tumor Volume (MTV), Interim Positron Emission Tomography (iPET) and Outcome in the PETAL Trial

Julia Richter, PhD, Andreas Hüttmann, MD, Jan Rekowski, MSc, Christine Schmitz, MD, Selina Gärtner, MS, BS, Claudia Ose, MSc, Andreas Rosenwald, Martin-Leo Hansmann, Sylvia Hartmann, MD, Peter Moeller, MD, Hans-Heinrich Wacker, MD, Alfred Feller, Christoph Thorns, MD, Stefan P. Müller, MD, Ulrich Duehrsen, MD, Wolfram Klapper, MD

Blood (2018) 132 (Supplement 1): 4188.

https://doi.org/10.1182/blood-2018-99-112815

Published: 2018

Journal Articles

PARP14 Is a Novel Therapeutic Target in STAT6 mutant Follicular Lymphoma

Verena Passerini, PhD, Michael Boesl, Elisabeth Silkenstedt, MD, Elisa Osterode, Michael Heide, Robert Kridel, PhD MD, Christoph Ziegenhain, Annette M. Staiger, PhD, German Ott, MD, Monika Szczepanowski, PhD, Julia Richter, PhD, Wolfram Klapper, MD, Andreas Rosenwald, Wolfgang Enard, PhD, Wolfgang Hiddemann, Deepak Bararia, PhD, Zimber-Strobl Ursula, Dr., Oliver Weigert, MD

Blood (2018) 132 (Supplement 1): 2842.

https://doi.org/10.1182/blood-2018-99-118063

Published: 2018

Journal Articles

B-Cell Differentiation Dependent Classification of Diffuse Large B-Cell Lymphoma By the Nanostring Technology

Thomas Yssing Michaelsen, BS, Rasmus Froberg Brøndum, Senior Bioinformatician, Julia Richter, PhD, Wolfram Klapper, MD, Mads Albertsen, Associate Professor, Hans Erik Johnsen, MD Professor, Karen Dybkær, Professor, Tarec Christoffer El-Galaly, MD PhD, Martin Bøgsted, Professor

Blood (2017) 130 (Supplement 1): 3995.

https://doi.org/10.1182/blood.V130.Suppl_1.3995.3995

Published: 2017

Journal Articles

Identification of Blut, a Novel Long-Noncoding RNA Differentially Expressed in Burkitt Lymphoma

Blood (2015) 126 (23): 3875.

https://doi.org/10.1182/blood.V126.23.3875.3875

Published: 2015

Journal Articles

The PRDX2 gene is transcriptionally silenced and de novo methylated in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma

Markus Schneider, Marcin Szaumkessel, Julia Richter, Ole Ammerpohl, Martin-Leo Hansmann, Ralf Küppers, Reiner Siebert, Maciej Giefing

Blood (2014) 123 (23): 3672–3674.

https://doi.org/10.1182/blood-2014-02-553263

Published: 2014

Journal Articles

A recurrent 11q aberration pattern characterizes a subset of MYC -negative high-grade B-cell lymphomas resembling Burkitt lymphoma

Blood (2014) 123 (8): 1187–1198.

https://doi.org/10.1182/blood-2013-06-507996

Published: 2014

Includes: Supplemental data

Journal Articles

TP53 Mutation Is an Independent Predictor of Poor Survival in Untreated Patients with CD20 + Aggressive B-Cell Lymphoma: Analysis within the Ricover-60 Trial

Thorsten Zenz, MD, Markus Kreuz, Doris Winter, Hanne Helfrich, Maxi Fuge, Heike Horn, MD, Julia Richter, PhD, Reiner Siebert, Lorenz Truemper, MD, Norbert Schmitz, MD, Markus Loeffler, Wolfram Klapper, Andreas Rosenwald, MD, Hartmut Döhner, MD, Michael Pfreundschuh, MD, German Ott, MD, Stephan Stilgenbauer, MD

Blood (2012) 120 (21): 546.

https://doi.org/10.1182/blood.V120.21.546.546

Published: 2012

Journal Articles

Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults

Blood (2011) 118 (1): 139–147.

https://doi.org/10.1182/blood-2011-01-330795

Published: 2011

Includes: Supplemental data

Journal Articles

New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling

Blood (2009) 113 (11): 2488–2497.

https://doi.org/10.1182/blood-2008-04-152900

Published: 2009

Includes: Supplemental data

NARROW

SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features

The Position of MYC Rearrangements in the Genomic Landscape of Diffuse Large B-Cell Lymphoma

An EZH2 Gene Expression Signature Is Predictive of Differential Efficacy of Chemotherapy Irrespective of EZH2 Mutation Status in Patients with Follicular Lymphoma Treated within the Gallium Trial

Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B Cell Precursor Acute Lymphoblastic Leukemia

Combining PET Radiomic Features with MYC Gene Rearrangement Results in High Prediction of Outcome in Diffuse Large B-Cell Lymphoma

Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1

Evaluation of the m7-FLIPI in Patients with Follicular Lymphoma Treated within the Gallium Trial: EZH2 mutation Status May be a Predictive Marker for Differential Efficacy of Chemotherapy

A New Stromal Signature Applicable to Formalin-Fixed Paraffin-Embedded Tissues Identifies Patients at Risk in Prospective Clinical Trials of the German High-Grade Non-Hodgkin Lymphoma Study Group

Molecular Characteristics of Diffuse Large B-Cell Lymphoma and Correlation with Baseline Metabolic Tumor Volume (MTV), Interim Positron Emission Tomography (iPET) and Outcome in the PETAL Trial

PARP14 Is a Novel Therapeutic Target in STAT6 mutant Follicular Lymphoma

B-Cell Differentiation Dependent Classification of Diffuse Large B-Cell Lymphoma By the Nanostring Technology

Identification of Blut, a Novel Long-Noncoding RNA Differentially Expressed in Burkitt Lymphoma

The PRDX2 gene is transcriptionally silenced and de novo methylated in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma

A recurrent 11q aberration pattern characterizes a subset of MYC -negative high-grade B-cell lymphomas resembling Burkitt lymphoma

TP53 Mutation Is an Independent Predictor of Poor Survival in Untreated Patients with CD20 + Aggressive B-Cell Lymphoma: Analysis within the Ricover-60 Trial

Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults

New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only